Navigation Links
Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event

PARSIPPANY, N.J., Jan. 12, 2011 /PRNewswire/ -- In 2011, what will be the major trends in the pharmaceutical industry?  What will drive innovation?  How will government regulations affect what's next and what's new?  What will the game changers be?  Who will survive in the competitive corporate landscape?  When it comes to market research, what's the smartest and most effective way to get the job done right? The answers to these questions and much more will be revealed at a pivotal, groundbreaking event - the Pharma Market Research Conference on February 1-2, in Parsippany, New Jersey.

The Pharma Market Research Conference is your EXCLUSIVE ENTRY into the world of pharmaceutical market research.  This is the most important and impactful event in pharmaceutical market research.  Nowhere else will you find the industry's best and brightest all under one roof!  

Located in the heart of New Jersey's Pharmaceutical Corridor, this event is an essential destination that shines a spotlight on the pharma industry for the world's most noteworthy market research executives.

The Pharma Market Research Conference's impressive advisory board includes senior-level thought leaders from Bayer, Eisai, Johnson & Johnson, Lundbeck, Merck, Pfizer, Purdue, Shire, and Takeda.  With their executive leadership, the Pharma Market Research Conference offers an intensive agenda for anyone wanting to network with and learn from the industry's best.

Talented speakers come from world class companies, including Abbott, Acorda Therapeutics, Alkermes, Allergan, AstraZeneca, Covidien, Daiichi Sankyo, Eisai, Johnson & Johnson, Lundbeck, Merck, Novartis, Pfizer, Roche, Shire, Takeda, ViroPharma & more!  For more about the speakers, go to:

See what exciting innovations and solutions are being offered by 2011's premier sponsors/exhibitors, which include Ipsos Health, Segmedica, Affinnova, A+A Research, BioMedTracker, CBR Pharma Insights, ClarityQMR, Docnography, Dolcera, Drug Development Insights, Epocrates, Financial Times, Healogix, HRA Research, Life Science Analytics, ListenLogic, M3 Global Research, Medefield, MedPredict, Murray Hill Center, National Analysts Worldwide, Northern Light, Optimal Strategix, Reckner, The Research Partnership, Survey Sampling, Toluna, Truth On Call, Verilogue, and WorldOne.

The Pharma Market Research Conference only happens once a year.  More than 200 people came last time; 2011 is expected to be even bigger and better.  For more information or to register, call + or go to:

SOURCE Pharma Market Research Conference
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)...  ARKRAY USA , Inc., a ... demonstrating the accuracy of its blood glucose meter systems. ... Diabetes and Cardiovascular Disease in Los Angeles ... ® 01 meter and the Assure ® ... to accurately measure glucose levels in blood is essential ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... 2015 American Dental Association meeting in Washington D.C. revolved around the fact that proper ... overall health. The talk stressed the link between periodontal disease (more commonly referred to ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, from Hopkinsville, Ky., ... medications at home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC ... In doing so, it could help to prevent potential overdose situations. As a ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... Bangalore, Karnataka (PRWEB) , ... November 27, 2015 ... ... the world, Health-E-minds, an innovative online platform for mental health and wellness consultation, ... KleverKid. , This partnership will bridge the knowledge gap experienced by parents and ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... contact center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term ... fully supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of ...
Breaking Medicine News(10 mins):